SAN DIEGO, Dec. 08, 2023 (GLOBE NEWSWIRE) — Johnson Fistel, LLP notifies investors of DermTech, Inc. (NASDAQ: DMTK) a securities class action lawsuit has been filed. The lawsuit seeks to recover losses on behalf of investors who acquired securities between May 3, 2022 and November 3, 2022, both dates inclusive (the “Class Period”). Investors have until December 15, 2023, to apply to the Court to be appointed as lead plaintiff in the lawsuit.
If you would like to review the complaint and join the class action please follow the link below for more information:
There is no cost or obligation to you.
Complaint Allegations: According to the lawsuit, throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that the Company experienced challenges with collections from commercial payors; (2) that, as a result, there was a lower average selling price for DermTech’s DMT; (3) that, as a result of the foregoing, the Company’s revenue growth would be adversely impacted; and (4) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.
What can Investors Do: Shareholders who incurred losses during the class period, have until December 15, 2023, to move the court to become a lead plaintiff in this action. A lead plaintiff will act on behalf of all other class members in directing the class-action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the class-action lawsuit. An investor’s ability to share any potential future recovery of the class action lawsuit is not dependent upon serving as lead plaintiff.
About Johnson Fistel, LLP:
Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York, Georgia, and Colorado. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonfistel.com.
Attorney advertising.
Past results do not guarantee future outcomes.
Services may be performed by attorneys in any of our offices.
Johnson Fistel, LLP has paid for the dissemination of this promotional communication, and Frank J. Johnson is the attorney responsible for its content.
Contact:
Johnson Fistel, LLP
501 W. Broadway, Suite 800, San Diego, CA 92101
James Baker, Investor Relations or Frank J. Johnson, Esq., (619) 814-4471
jimb@johnsonfistel.com or fjohnson@johnsonfistel.com
- Robotic Surgery Is No Longer the Future—It’s the Revenue Engine of Healthcare | MarketsandMarkets™. - July 3, 2025
- SEALSQ Corp Announces H1 2025 Preliminary Revenue and Other Key Financial Metrics: Updates on Planned Deployment of Post-Quantum Security Solutions by 2025 Year-End - July 3, 2025
- Quadient recognized for the quality of its financial communication at the 2025 Transparency Awards - July 3, 2025
